BILINSKY IGOR Insider Trades

Insider Trading History

Track insider trading activity for BILINSKY IGOR. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $595k 133,920 shares
Last Trade
Jun 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$16.8k 3,976 shares
$4.23
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $612k 137,896 shares
Last Trade
Jun 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $243k 54,691 shares
Last Trade
Jun 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33k 7,813 shares
$4.23
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $597k 134,556 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.8k 8,790 shares
$3.96
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $578k 130,083 shares
Last Trade
Jun 01, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$17.7k 4,473 shares
$3.96
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $117k 26,369 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$34.8k 8,790 shares
$3.96
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $522k 117,500 shares
Last Trade
Mar 09, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$636k 117,500 shares
$5.41
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $558k 125,766 shares
Last Trade
Mar 05, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$76.2k 16,628 shares
$4.58
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $278k 62,504 shares
Last Trade
Mar 05, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $632k 142,394 shares
Last Trade
Mar 05, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$143k 31,246 shares
$4.58
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $0 0 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$13.3k 3,517 shares
$3.79
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $156k 35,159 shares
Last Trade
Mar 02, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$33.3k 8,790 shares
$3.79
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $524k 118,051 shares
Last Trade
Mar 02, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$46.6k 12,307 shares
$3.79
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $493k 111,148 shares
Last Trade
Mar 02, 2026 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$26.2k 6,903 shares
$3.79
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $470k 105,744 shares
Last Trade
Dec 02, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$3.82k 1,786 shares
$2.14
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $477k 107,530 shares
Last Trade
Dec 02, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.51k 3,516 shares
$2.14
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $15.6k 3,517 shares
Last Trade
Dec 02, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.51k 3,516 shares
$2.14
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $482k 108,478 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $195k 43,949 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.6k 8,789 shares
$2.23
$4.44
Iovance Biotherapeutics
Iovance Biotherapeutics IOVA
Chief Operating Officer
Holding Value $462k 104,014 shares
Last Trade
Dec 01, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$9.95k 4,464 shares
$2.23
$4.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up